Related Experiment Video
Updated: Jul 18, 2026
Non-restraining EEG Radiotelemetry: Epidural and Deep Intracerebral Stereotaxic EEG Electrode Placement
Published on: June 25, 2016
MDMA and seizures: a dangerous liaison?
Filippo S Giorgi1, Gloria Lazzeri, Gianfranco Natale
1M.D. Department of Human Morphology and Applied Biology, University of Pisa, via Roma 55, 56126 Pisa, Italy.
Abstract:
In the past decades, there was a massive increase in the abuse of methylenedioxymethamphetamine (MDMA) in the Western countries. Seizure onset after MDMA is considered to be related mainly to its acute systemic effects (e.g., hyponatremia and hyperthermia). However, additional mechanisms might concur to it as well. Experiments aimed at disclosing the basis for such an acute effect have the advantage of profiting of controlled conditions and the "pure" compounds, as opposed to the limits of clinical data which are biased by several confounding factors. Amphetamines exert profound effect on different monoaminergic systems, which might participate to lowering of seizure threshold. Chronic effects of MDMA abuse on seizure threshold have not been explored in detail so far. Recent data showed that in mice receiving small, repeated doses of MDMA, a persisting pro-convulsant effect toward limbic seizures and metabolic hyperexcitability can be observed. In the present article, we reviewed these studies and we report our preliminary experimental data documenting the lack of mossy fiber sprouting at short time intervals following MDMA, when seizure susceptibility is already present.
Insights
Methylenedioxymethamphetamine (MDMA) abuse can lower seizure threshold. Repeated MDMA doses in mice show lasting pro-convulsant effects, but early stages lack mossy fiber sprouting, suggesting other mechanisms are involved.
Area of Science:
- Neuroscience
- Pharmacology
- Toxicology
Background:
- Methylenedioxymethamphetamine (MDMA) abuse has increased, with seizures linked to acute effects like hyponatremia and hyperthermia.
- Amphetamines, including MDMA, impact monoaminergic systems, potentially lowering seizure threshold.
- Chronic MDMA abuse effects on seizure threshold remain underexplored.
Purpose of the Study:
- To investigate the mechanisms underlying MDMA-induced seizures.
- To explore the chronic effects of MDMA on seizure susceptibility.
- To examine the role of specific neurobiological changes in MDMA-related seizures.
Main Methods:
- Review of existing studies on MDMA and seizure threshold.
- Experimental data collection in mice using controlled MDMA administration.
- Histological analysis to assess mossy fiber sprouting at short time intervals post-MDMA.
Main Results:
- Recent data indicate that small, repeated MDMA doses in mice induce persistent pro-convulsant effects and metabolic hyperexcitability.
- Preliminary data show no mossy fiber sprouting in mice at early time points after MDMA, despite increased seizure susceptibility.
- This suggests that mechanisms other than mossy fiber sprouting contribute to acute MDMA-induced seizure susceptibility.
Conclusions:
- While acute MDMA effects are known contributors to seizures, chronic abuse may lead to lasting pro-convulsant states.
- The absence of early mossy fiber sprouting indicates that other neurobiological alterations are responsible for the immediate increase in seizure susceptibility following MDMA exposure.
- Further research is needed to fully elucidate the complex mechanisms of MDMA-induced seizures.
Related Concept Videos
01:20Seizures l: Introduction
01:24Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
01:20Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
01:22CNS Stimulants: Psychedelic Agents
01:14Antiepileptic Drugs: Glutamate Antagonists
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...